These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38402662)

  • 21. Corrigendum to "ACVR1
    Matsuo K; Lepinski A; Chavez RD; Barruet E; Pereira A; Moody TA; Ton AN; Sharma A; Hellman J; Tomoda K; Nakamura MC; Hsiao EC
    Bone; 2022 May; 158():116325. PubMed ID: 35241401
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to "RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA" [Exp. Cell Res. 399 (1) (1 February 2021) 112453].
    Wang Q; Guo Y; Wang W; Liu B; Yang G; Xu Z; Li J; Liu Z
    Exp Cell Res; 2021 Nov; 408(2):112867. PubMed ID: 34648845
    [No Abstract]   [Full Text] [Related]  

  • 23. MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2.
    Yang C; Zhan H; Zhao Y; Wu Y; Li L; Wang H
    Cell Death Dis; 2021 Jan; 12(1):14. PubMed ID: 33414423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way.
    Fang S; Zheng L; Chen X; Guo X; Ding Y; Ma J; Ding J; Chen W; Yang Y; Chen M; Zhao Z; Tu J; Ji J
    Hepatol Int; 2023 Dec; 17(6):1500-1518. PubMed ID: 37460832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum to "Neurturin promotes tumor cell motility and angiogenesis in colorectal cancer" [Exp. Cell Res. 413 (2022) 113049].
    Wang S; Nie L; Song Y; Zhang F; Chen X; Shi W; Yang Z; Sun Y; Dang Q; Gao A
    Exp Cell Res; 2022 Aug; 417(1):113206. PubMed ID: 35584556
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
    Zhang P; Su T; Zhang S
    J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: Gul A, Gul M. Intracutaneous sterile water injection for pain relief during extracorporeal shock wave lithotripsy: comparison with diclofenac sodium. Urolithiasis. 2020 Apr;48(2):103-108. doi:10.1007/s00240-019-01147-9. Epub 2019 Jul 5.
    Aras B; Uruç F; Ivelik HI
    Urolithiasis; 2021 Aug; 49(4):385. PubMed ID: 33123746
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to: Coexistence of alcohol-related pancreatitis and alcohol-related liver disease: A systematic review and meta-analysis [Pancreatology. 2020 Sep; 20(6): 1069-1077. Epub 2020 Jul 30].
    Singhvi A; Abromitis R; Althouse AD; Bataller R; Arteel GE; Yadav D
    Pancreatology; 2022 Mar; 22(2):338. PubMed ID: 34991970
    [No Abstract]   [Full Text] [Related]  

  • 29. RNA-Binding Protein MEX3A Interacting with DVL3 Stabilizes Wnt/β-Catenin Signaling in Endometrial Carcinoma.
    Yang P; Zhang P; Zhang S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MEX3A induces the development of thyroid cancer via targeting CREB1.
    Feng G; Wang P; Zhang H; Cheng S; Xing Y; Wang Y
    Cell Biol Int; 2023 Nov; 47(11):1843-1853. PubMed ID: 37529875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MEX3A promotes angiogenesis in colorectal cancer via glycolysis.
    Lu Y; Bi T; Zhou S; Guo M
    Libyan J Med; 2023 Dec; 18(1):2202446. PubMed ID: 37155144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying the E2F3-MEX3A-KLF4 signaling axis that sustains cancer cells in undifferentiated and proliferative state.
    Yang X; Li G; Tian Y; Wang X; Xu J; Liu R; Deng M; Shao C; Pan Y; Wu X; Li M; Zhang C; Liu R; Qin J; Zhang C; Liu Z; Wu X; Plikus MV; Lengner CJ; Zheng Z; Lv C; Yu Z
    Theranostics; 2022; 12(16):6865-6882. PubMed ID: 36276637
    [No Abstract]   [Full Text] [Related]  

  • 33. CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness.
    Pereira B; Sousa S; Barros R; Carreto L; Oliveira P; Oliveira C; Chartier NT; Plateroti M; Rouault JP; Freund JN; Billaud M; Almeida R
    Nucleic Acids Res; 2013 Apr; 41(7):3986-99. PubMed ID: 23408853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMYD2 epigenetically activates MEX3A and suppresses CDX2 in colorectal cancer cells to augment cancer growth.
    Pan L; Fan Y; Zhou L
    Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):959-969. PubMed ID: 35637161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer.
    Yang D; Jiao Y; Li Y; Fang X
    PeerJ; 2020; 8():e8252. PubMed ID: 31998552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum to: "Correlation of pesticide exposure from dietary intake and bio-monitoring: The different sex and socio-economic study of children" [Ecotoxicol. Environ. Saf., vol. 162 (2018) pp. 170-177 Epub 2018 Jul 4].
    Sinha SN; Banda VR
    Ecotoxicol Environ Saf; 2023 Sep; 263():115362. PubMed ID: 37586195
    [No Abstract]   [Full Text] [Related]  

  • 37. Corrigendum to "Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion". J Affect Disord. 2018 Dec 1;241:1-7. doi: 10.1016/j.jad.2018.07.033. Epub 2018 Jul 27.
    Chen MH; Lin WC; Wu HJ; Cheng CM; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Su TP
    J Affect Disord; 2020 Sep; 274():1219. PubMed ID: 32663957
    [No Abstract]   [Full Text] [Related]  

  • 38. RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma.
    Qiu Y; Meng M; Cao C; Zhang J; Cheng X; Huang Y; Cao H; Li Y; Tian D; Huang Y; Peng L; Hu K; Zhang Y; Liao J; He J; Wang X; Lu D; Lin L; Bi X; Yin D
    Mol Ther Nucleic Acids; 2022 Mar; 27():241-255. PubMed ID: 34976441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p.
    Li H; Liang J; Wang J; Han J; Li S; Huang K; Liu C
    Cancer Commun (Lond); 2021 Jun; 41(6):472-491. PubMed ID: 33638620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of insulin-like growth factor-1 receptor (IGF-1R) promotes growth of colorectal cancer through triggering the MEX3A-mediated degradation of RIG-I.
    Xie Q; Chu Y; Yuan W; Li Y; Li K; Wu X; Liu X; Xu R; Cui S; Qu X
    Acta Pharm Sin B; 2023 Jul; 13(7):2963-2975. PubMed ID: 37521868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.